Fibromuscular dysplasia classification: Difference between revisions
Jump to navigation
Jump to search
| (One intermediate revision by one other user not shown) | |||
| Line 4: | Line 4: | ||
{{CMG}}; {{AE}} {{M.B}} | {{CMG}}; {{AE}} {{M.B}} | ||
==Overview== | ==Overview== | ||
The classification system for fibromuscular dysplasia (FMD) was first according to the arterial layer involved. ([[tunica intima]], [[tunica media]] , or [[adventitia]]) . However, with use of transluminal [[percutaneous]] [[angioplasty]] (TPA) for treatment of FMD lesions and its preference rather than surgery, the obtaining of pathological specimens are restricted. Thus, today, FMD is a disease diagnosed radiographically and histopathological classification has been replaced by the [[Arteriography|arteriographic]] findings. | |||
==Classification== | ==Classification== | ||
Fibromuscular dysplasia may be classified according to [[Angiogram|angiographic]] findings or [[histological]] characteristics, as below: | Fibromuscular dysplasia may be classified according to [[Angiogram|angiographic]] findings or [[histological]] characteristics, as below: | ||
'''Angiografic classification''' <ref>Persu A, Touze E, Mousseaux E, Barral X, Joffre F, Plouin PF. Diagnosis | '''Angiografic classification:''' <ref>Persu A, Touze E, Mousseaux E, Barral X, Joffre F, Plouin PF. Diagnosis | ||
and management of fibromuscular dysplasia: an expert consensus. Eur J | and management of fibromuscular dysplasia: an expert consensus. Eur J | ||
Clin Invest. 2012;42:338–347</ref> | Clin Invest. 2012;42:338–347</ref> | ||
| Line 30: | Line 30: | ||
}}</ref> | }}</ref> | ||
=== Histological classification === | === Histological classification: === | ||
In this classification system, FMD is categorized according to the arterial layer involved. | In this classification system, FMD is categorized according to the arterial layer involved. | ||
This subtype | '''Medial dysplasia''' | ||
*Medial [[dysplasia]] is the most common type of FMD and is accounting for more than eighty percent of fibromuscular lesions. | |||
*Medial FMD is further subdivided into three subtypes: '''medial fibroplasia, perimedial fibroplasia, and medial hyperplasia.''' | |||
**'''Medial [[fibroplasia]]''' microscopically is accompanied by alternating areas of thinned and thickened [[Anatomical terms of location|media]]. Thickened area are fibromuscular ridges containing [[collagen]] as well thinned areas are due to smooth muscle and [[internal elastic lamina]] loss with resultant arterial [[stenosis]] alternating with [[dilatation]]. This subtype corresponds angiographically to the classic "string of beads" appearance. | |||
**'''''Perimedial fibroplasia''''' is associated with [[collagen]] deposition in the outer half of the media; and medial hyperplasia, in which there is true smooth muscle [[hyperplasia]] without significant fibrosis as well as collagen deposition<ref name="pmid1131001">{{cite journal |vauthors=Stanley JC, Gewertz BL, Bove EL, Sottiurai V, Fry WJ |title=Arterial fibrodysplasia. Histopathologic character and current etiologic concepts |journal=Arch Surg |volume=110 |issue=5 |pages=561–6 |date=May 1975 |pmid=1131001 |doi= |url=}}</ref> | |||
'' | ==== '''Intimal fibroplasia''' ==== | ||
*Intimal fibroplasia is caused by circumferential or eccentric deposition of collagen in the intima. The [[internal elastic lamina]] may be intact, fragmented, or duplicated. There is no inflammatory or [[lipid]] component. This subtype corresponds angiografically to Focal FMD. | |||
==== Adventitial disease ==== | |||
*Adventitial disease, a rare manifestation of FMD, is caused by replacement of [[fibrous tissue]] of [[Adventitia|adventitia]] with dense [[collagen]], collagen deposition may extend into the periarterial tissue, with accompanying [[inflammation]] and focal [[Infiltration (medical)|infiltration]] of [[lymphocytes]]. | |||
*Adventitial disease, | |||
==References== | ==References== | ||
Latest revision as of 22:16, 19 August 2018
|
Fibromuscular dysplasia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
ASA/ACCF/AHA Guideline Recommendations |
|
Management of Patients With Fibromuscular Dysplasia of the Extracranial Carotid Arteries |
|
Case Studies |
|
Fibromuscular dysplasia classification On the Web |
|
American Roentgen Ray Society Images of Fibromuscular dysplasia classification |
|
Risk calculators and risk factors for Fibromuscular dysplasia classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohsen Basiri M.D.
Overview
The classification system for fibromuscular dysplasia (FMD) was first according to the arterial layer involved. (tunica intima, tunica media , or adventitia) . However, with use of transluminal percutaneous angioplasty (TPA) for treatment of FMD lesions and its preference rather than surgery, the obtaining of pathological specimens are restricted. Thus, today, FMD is a disease diagnosed radiographically and histopathological classification has been replaced by the arteriographic findings.
Classification
Fibromuscular dysplasia may be classified according to angiographic findings or histological characteristics, as below:
Angiografic classification: [1]
- Multifocal FMD
- With angiographic appearance of a "string of beads" due to multiple areas of stenosis and dilatation(image?) this subtype corresponds pathologically to medial fibroplasia.
- Focal FMD
- This form is less common , and it has the angiographic appearance of a "circumferential or tubular stenosis" and corresponds pathologically to intimal fibroplasia, medial hyperplasia and periarterial hyperplasia are histologic types that may also have a focal appearance.
It has been shown that these two different angiographic subtypes of FMD (multifocal and focal) have different phenotypic presentations and natural history.[2]
Histological classification:
In this classification system, FMD is categorized according to the arterial layer involved.
Medial dysplasia
- Medial dysplasia is the most common type of FMD and is accounting for more than eighty percent of fibromuscular lesions.
- Medial FMD is further subdivided into three subtypes: medial fibroplasia, perimedial fibroplasia, and medial hyperplasia.
- Medial fibroplasia microscopically is accompanied by alternating areas of thinned and thickened media. Thickened area are fibromuscular ridges containing collagen as well thinned areas are due to smooth muscle and internal elastic lamina loss with resultant arterial stenosis alternating with dilatation. This subtype corresponds angiographically to the classic "string of beads" appearance.
- Perimedial fibroplasia is associated with collagen deposition in the outer half of the media; and medial hyperplasia, in which there is true smooth muscle hyperplasia without significant fibrosis as well as collagen deposition[3]
Intimal fibroplasia
- Intimal fibroplasia is caused by circumferential or eccentric deposition of collagen in the intima. The internal elastic lamina may be intact, fragmented, or duplicated. There is no inflammatory or lipid component. This subtype corresponds angiografically to Focal FMD.
Adventitial disease
- Adventitial disease, a rare manifestation of FMD, is caused by replacement of fibrous tissue of adventitia with dense collagen, collagen deposition may extend into the periarterial tissue, with accompanying inflammation and focal infiltration of lymphocytes.
References
- ↑ Persu A, Touze E, Mousseaux E, Barral X, Joffre F, Plouin PF. Diagnosis and management of fibromuscular dysplasia: an expert consensus. Eur J Clin Invest. 2012;42:338–347
- ↑ Sebastien Savard, Olivier Steichen, Arshid Azarine, Michel Azizi, Xavier Jeunemaitre & Pierre-Francois Plouin (2012). "Association between 2 angiographic subtypes of renal artery fibromuscular dysplasia and clinical characteristics". Circulation. 126 (25): 3062–3069. doi:10.1161/CIRCULATIONAHA.112.117499. PMID 23155180. Unknown parameter
|month=ignored (help) - ↑ Stanley JC, Gewertz BL, Bove EL, Sottiurai V, Fry WJ (May 1975). "Arterial fibrodysplasia. Histopathologic character and current etiologic concepts". Arch Surg. 110 (5): 561–6. PMID 1131001.